LNCAROD enhanced its mRNA stability through m6A methylation modification, and a complex with HSPA1A and YBX1 promoted the progression of head and neck squamous cell carcinoma (Ban et al., 2020). The gene discussed is HSPA1A; the disease is head and neck squamous cell carcinoma.